These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 32236239)

  • 1. Human serum albumin-based doxorubicin prodrug nanoparticles with tumor pH-responsive aggregation-enhanced retention and reduced cardiotoxicity.
    Zhang B; Wan S; Peng X; Zhao M; Li S; Pu Y; He B
    J Mater Chem B; 2020 May; 8(17):3939-3948. PubMed ID: 32236239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-stimuli responsive mesoporous carbon nano-platform gated by human serum albumin for cancer thermo-chemotherapy.
    Zhao Q; Wang X; Yang M; Li X; Mao Y; Guan X; Di D; Wang S
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110532. PubMed ID: 31590051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A self-assembled pH/enzyme dual-responsive prodrug with PEG deshielding for multidrug-resistant tumor therapy.
    Ni R; Zhu J; Xu Z; Chen Y
    J Mater Chem B; 2020 Feb; 8(6):1290-1301. PubMed ID: 31967176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy.
    Xiong S; Wang Z; Liu J; Deng X; Xiong R; Cao X; Xie Z; Lei X; Chen Y; Tang G
    Colloids Surf B Biointerfaces; 2019 Jan; 173():346-355. PubMed ID: 30316081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active-targeting and acid-sensitive pluronic prodrug micelles for efficiently overcoming MDR in breast cancer.
    Xu C; Xu J; Zheng Y; Fang Q; Lv X; Wang X; Tang R
    J Mater Chem B; 2020 Apr; 8(13):2726-2737. PubMed ID: 32154530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-Sensitive nanoparticles based on amphiphilic imidazole/cholesterol modified hydroxyethyl starch for tumor chemotherapy.
    Xu Z; Yang D; Long T; Yuan L; Qiu S; Li D; Mu C; Ge L
    Carbohydr Polym; 2022 Feb; 277():118827. PubMed ID: 34893244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and in Vitro Analysis of Human Serum Albumin Nanoparticles Loaded with Anthracycline Derivatives.
    Kimura K; Yamasaki K; Nakamura H; Haratake M; Taguchi K; Otagiri M
    Chem Pharm Bull (Tokyo); 2018; 66(4):382-390. PubMed ID: 29607904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
    Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
    Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stepwise dual pH and redox-responsive cross-linked polypeptide nanoparticles for enhanced cellular uptake and effective cancer therapy.
    Qu J; Wang R; Peng S; Shi M; Yang ST; Luo JB; Lin J; Zhou QH
    J Mater Chem B; 2019 Dec; 7(45):7129-7140. PubMed ID: 31663585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabricating an intelligent cell-like nano-prodrug via hierarchical self-assembly based on the DNA skeleton for suppressing lung metastasis of breast cancer.
    Li Y; Yan T; Chang W; Cao C; Deng D
    Biomater Sci; 2019 Aug; 7(9):3652-3661. PubMed ID: 31169833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-triggered drug-release vehicles for synergistic cancer therapy.
    Tu TY; Yang SJ; Tsai MH; Wang CH; Lee SY; Young TH; Shieh MJ
    Colloids Surf B Biointerfaces; 2019 Jan; 173():788-797. PubMed ID: 30384276
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Dong Y; Du P; Liu P
    Int J Pharm; 2020 Oct; 588():119723. PubMed ID: 32755688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodrug-Based Nanoreactors with Tumor-Specific
    Ren C; Liu H; Lv F; Zhao W; Gao S; Yang X; Jin Y; Tan Y; Zhang J; Liang XJ; Li Z
    ACS Appl Mater Interfaces; 2020 Aug; 12(31):34667-34677. PubMed ID: 32610896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric prodrug microspheres with tumor intracellular microenvironment bioreducible degradation, pH-triggered "off-on" fluorescence and drug release for precise imaging-guided diagnosis and chemotherapy.
    Pei M; Li G; Ma K; Li J; Wang Y; Liu P
    Colloids Surf B Biointerfaces; 2019 May; 177():313-320. PubMed ID: 30771583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity.
    Zhao S; Yu Q; Pan J; Zhou Y; Cao C; Ouyang JM; Liu J
    Acta Biomater; 2017 May; 54():294-306. PubMed ID: 28267598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of responsive "dual-lock" nanoparticles and their application in collaborative therapy based on CuS coordination.
    Jia C; Zhang M; He XW; Li WY; Zhang YK
    J Mater Chem B; 2021 Jan; 9(4):1049-1058. PubMed ID: 33399610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
    Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH Responsiveness of Hexosomes and Cubosomes for Combined Delivery of
    Li Y; Angelova A; Hu F; Garamus VM; Peng C; Li N; Liu J; Liu D; Zou A
    Langmuir; 2019 Nov; 35(45):14532-14542. PubMed ID: 31635451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phosphorylcholine-based zwitterionic copolymer coated ZIF-8 nanodrug with a long circulation time and charged conversion for enhanced chemotherapy.
    Xie R; Yang P; Peng S; Cao Y; Yao X; Guo S; Yang W
    J Mater Chem B; 2020 Jul; 8(28):6128-6138. PubMed ID: 32568335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced in vitro antitumor efficacy of a polyunsaturated fatty acid-conjugated pH-responsive self-assembled ion-pairing liposome-encapsulated prodrug.
    Wang Y; Fan P; Zhu L; Zhuang W; Jiang L; Zhang H; Huang H
    Nanotechnology; 2020 Apr; 31(15):155101. PubMed ID: 31846941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.